The evidence reported here suggests that paeoniflorin might be a suitable complementary agent for patients with IFN-α-induced depression because of its excellent anti-neuroinflammatory effects as well as its antidepressant effects in the major emotion-related regions. This evidence concerns the gene IFNA2 and depressive disorder.